We are EVolution Therapeutics, an innovative biotech spin-out from Aston University with a visionary mission: to revolutionise the treatment of inflammatory diseases, starting with our pioneering work in wound healing therapies.
Non-healing wounds have reached crisis proportions within our healthcare system. In 2018, the NHS managed 3.8 million patients for wounds, costing £8.3 billion annually, with £5.6 billion spent on non-healing wounds, (the same cost as managing obesity). Current treatments largely rely on passive wound management strategies (i.e. wound dressings) with the majority of care taking place in the community (54.4 million community nurse visits annually), underscoring the pressing need for advanced wound care therapies.
We have a vision of translating our pioneering academic research, into a revolutionary EV based therapy which actively accelerates wound healing, in contrast to current anti-inflammatory and passive wound management treatments.
🤝 Let's Connect and Innovate
We firmly believe that collaboration is the driving force behind innovation. If you share our passion for transforming healthcare or have opportunities for partnership, let's connect. Together, we can make a lasting impact on the treatment of inflammatory disease.
Company Details
Evolution Therapeutics Ltd Questions
Evolution Therapeutics Ltd's website is http://www.evolutiontherapeutics.com
Evolution Therapeutics Ltd's LinkedIn profile is https://uk.linkedin.com/company/evolution-therapeutics
Evolution Therapeutics Ltd has
6 employees.
View email and phone details for 6
employees at Evolution Therapeutics Ltd.
Evolution Therapeutics Ltd's industry is
Biotechnology Research
Evolution Therapeutics Ltd's top competitors are
Genie Fertility,
Evox Therapeutics Ltd,
Fibraxis,
Cryologyx,
Quantified Imaging,
Hero Ai,
Amilis,
Sona Health,
Exgen Dx,
Avid Health.
Evolution Therapeutics Ltd's categories are Biotechnology Research
Evolution Therapeutics Ltd's founding year is 2022
